4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-21-069084
Chief Financial Officer acquired 500,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Andrew Chief Financial Officer | 2021-12-10 | Option exercise | +500,000 | $0.32 | $160,000 | 553,500 | D |
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2021-12-10 | Option exercise · Share Options (right to buy) | −500,000 | 5,384,820 | D | ||
Loading xslF345X03/doc4.xml…